Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been given a consensus recommendation of “Buy” by the eight research firms that are currently covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have updated their coverage on the […]
Jasper Therapeutics, Inc (NASDAQ:JSPR) Receives $64 17 Average PT from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Investment analysts at Evercore ISI assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Get Free Report) in a note issued to investors on Wednesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $65.00 price target on the stock. Evercore ISI’s price target would indicate a potential upside of 136.02% from the stock’s […]
Jasper Therapeutics (NASDAQ:JSPR) Receives Outperform Rating from Oppenheimer theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 276,200 shares, a growth of 43.5% from the January 15th total of 192,500 shares. Based on an average daily volume of 109,400 shares, […]